2025
SJR Q1
JCR Q2 · 2,5
SCIE
Journal detail
Archives of Dermatological Research
- Country
- Germany · Western Europe
- Type
- journal
- ISSN
-
034036961432069X
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,782
- Quartile Q1
- H-Index 101
- Cites/doc 1,97
- Docs (3y) 1.282
- Cites (3y) 2.555
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 2,5
- 5Y JIF 2,6
- JCI 0,76
WoS indexes
- SCIE
Subject classification
Categories (SJR)
Areas
WoS categories
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q2 | 0,782 | 2,5 | 2,6 | 0,76 | Q2 | 101 |
| 2024 | Q1 | Q3 | 0,879 | 2,1 | 2,5 | 0,76 | Q2 | 97 |
| 2023 | Q1 | Q3 | 0,816 | 1,8 | 2,4 | 0,84 | Q2 | 97 |
| 2022 | Q1 | Q2 | 0,887 | 3 | 3,1 | 1,07 | Q1 | 97 |
| 2021 | Q1 | Q2 | 0,891 | 3 | 3,2 | 1,08 | Q1 | 97 |
| 2020 | Q1 | Q2 | 0,776 | 3 | 3,2 | 0,97 | Q1 | 97 |
| 2019 | Q1 | Q2 | 0,856 | 2,3 | 2,6 | 1,01 | Q1 | 97 |
| 2018 | — | Q2 | — | 2,3 | 2,5 | 1 | Q2 | — |
| 2017 | Q1 | Q2 | 1,006 | 2,1 | 2,4 | 1,05 | Q1 | 97 |
| 2016 | Q1 | Q2 | 1,052 | 2,3 | 2,4 | — | — | 97 |
| 2015 | Q1 | Q2 | 0,967 | 2,1 | 2,2 | — | — | 97 |
| 2014 | Q1 | Q2 | 0,927 | 1,9 | 2,2 | — | — | 97 |
| 2013 | Q1 | Q2 | 1,064 | 2,3 | 2,3 | — | — | 97 |
| 2012 | Q1 | Q1 | 1,117 | 2,7 | 2,4 | — | — | 97 |
| 2011 | Q1 | Q2 | 1,034 | 2,3 | 2,2 | — | — | 97 |
| 2010 | Q1 | Q2 | 0,89 | 2 | 2,1 | — | — | 97 |
| 2009 | — | Q2 | — | 1,8 | 1,8 | — | — | — |
| 2008 | — | Q2 | — | 1,9 | 1,6 | — | — | — |
| 2007 | — | Q2 | — | 1,6 | 1,5 | — | — | — |
| 2006 | — | Q3 | — | 1,3 | — | — | — | — |
| 2005 | — | Q3 | — | 1,2 | — | — | — | — |
| 2004 | — | Q2 | — | 1,2 | — | — | — | — |
| 2003 | — | Q2 | — | 1,4 | — | — | — | — |
| 2002 | — | Q2 | — | 1,5 | — | — | — | — |
| 2001 | — | Q2 | — | 1,4 | — | — | — | — |
| 2000 | — | Q2 | — | 1,3 | — | — | — | — |
| 1999 | — | Q2 | — | 1,3 | — | — | — | — |
| 1998 | — | Q1 | — | 1,4 | — | — | — | — |
| 1997 | — | Q1 | — | 1,2 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | DERMATOLOGY | SCIE | Q2 | Q2 | 43/99 |
| 2024 | DERMATOLOGY | SCIE | Q3 | Q2 | 50/96 |
| 2023 | DERMATOLOGY | SCIE | Q3 | Q2 | 54/94 |
| 2022 | DERMATOLOGY | SCIE | Q2 | Q1 | 24/70 |
| 2021 | DERMATOLOGY | SCIE | Q2 | Q1 | 30/69 |
| 2020 | DERMATOLOGY | SCIE | Q2 | Q1 | 32/69 |
| 2019 | DERMATOLOGY | SCIE | Q2 | Q1 | 32/68 |
| 2018 | DERMATOLOGY | SCIE | Q2 | Q2 | 29/66 |
| 2017 | DERMATOLOGY | SCIE | Q2 | Q1 | 24/64 |
| 2016 | DERMATOLOGY | SCIE | Q2 | — | 21/63 |
| 2015 | DERMATOLOGY | SCIE | Q2 | — | 20/61 |
| 2014 | DERMATOLOGY | SCIE | Q2 | — | 23/63 |
| 2013 | DERMATOLOGY | SCIE | Q2 | — | 16/61 |
| 2012 | DERMATOLOGY | SCIE | Q1 | — | 12/59 |
| 2011 | DERMATOLOGY | SCIE | Q2 | — | 17/58 |
| 2010 | DERMATOLOGY | SCIE | Q2 | — | 20/55 |
| 2009 | DERMATOLOGY | SCIE | Q2 | — | 20/48 |
| 2008 | DERMATOLOGY | SCIE | Q2 | — | 19/43 |
| 2007 | DERMATOLOGY | SCIE | Q2 | — | 16/41 |
| 2006 | DERMATOLOGY | SCIE | Q3 | — | 21/39 |
| 2005 | DERMATOLOGY | SCIE | Q3 | — | 24/39 |
| 2004 | DERMATOLOGY | SCIE | Q2 | — | 17/38 |
| 2003 | DERMATOLOGY | SCIE | Q2 | — | 15/38 |
| 2002 | DERMATOLOGY & VENEREAL DISEASES | SCIE | Q2 | — | 13/40 |
| 2001 | DERMATOLOGY & VENEREAL DISEASES | SCIE | Q2 | — | 11/38 |
| 2000 | DERMATOLOGY & VENEREAL DISEASES | SCIE | Q2 | — | 11/36 |
| 1999 | DERMATOLOGY & VENEREAL DISEASES | SCIE | Q2 | — | 11/36 |
| 1998 | DERMATOLOGY & VENEREAL DISEASES | SCIE | Q1 | — | 8/35 |
| 1997 | DERMATOLOGY & VENEREAL DISEASES | SCIE | Q1 | — | 8/32 |